FDA rejects labeling claims on vitamin C-enhanced version of Vicks NyquilOctober 14th, 2009 FDA warns P&G for adding vitamin C to NyquilWASHINGTON — Federal drug regulators warned Procter & Gamble on Wednesday for adding Vitamin C to its Vicks cold formulas, a combination not allowed by federal regulations. The Food and Drug Administration said medications like Vicks Nyquil and Dayquil are not permitted to contain the vitamin.
Study: Heart patients who get the flu are more likely to have a heart attackSeptember 21st, 2009 Study: Flu viruses can spark heart attacksLONDON — Heart patients who catch the flu may have more to worry about than just a fever or the sniffles: the virus could also spark a heart attack, new research shows. Amid the global outbreak of swine flu, experts say it's crucial that heart patients get vaccinated against both regular flu and swine flu to avoid medical problems.
Federal judge orders MLB drug evidence preserved until gov't decides on Supreme Court appealSeptember 2nd, 2009 Federal judge orders MLB drug evidence preservedSAN FRANCISCO — A federal appellate judge has ordered the preservation of all evidence that allegedly shows 104 Major League Baseball players tested positive for steroids in 2003. The 9th U.S.
New anti-clotting drug reduces heart patients' chances of dyingAugust 30th, 2009 New drug reduces risks for heart patientsBARCELONA, Spain — A new drug to prevent blood clots in heart patients reduced their chances of dying by more than 20 percent compared to the standard treatment, new research says. Researchers followed 18,624 patients worldwide from 2006 to 2008.
AstraZeneca says Brilinta anti-clotting drug reduces chance of dying better than PlavixAugust 30th, 2009 New AstraZeneca drug reduces heart patients' risksBARCELONA, Spain — A new drug to prevent blood clots in heart patients reduced their chances of dying by more than 20 percent compared with the standard treatment, new research says. Researchers followed 18,624 patients worldwide from 2006 to 2008.
Teen trippin' on ADHD drugs can be a real downer; study finds surge in calls to poison centersAugust 24th, 2009 Teen trippin' on ADHD drugs can be a real downerCHICAGO — Calls to poison control centers about teens abusing attention-deficit drugs soared 76 percent over eight years, sobering evidence about the dangerous consequences of prescription misuse, a study shows. The calls were from worried parents, emergency room doctors and others seeking advice on how to deal with the problem, which can be deadly.
Contrave - Weight Loss Drug: How to participate in clinical trialJuly 21st, 2009 Contrave is an experimental weight-loss drug developed by Orexigen Therapeutics Inc. It has been shown to significantly aid weight loss
in three late-stage clinical trials.
ARYx shares fall on failed late-stage study for potential blood clot drug tecarfarinJuly 8th, 2009 ARYx shares fall on failed late-stage studyNEW YORK — Shares of ARYx Therapeutics Inc. plunged Wednesday after the biotechnology company said its experimental anticoagulant tecarfarin failed to meet a key treatment goal in a late-stage study.
Humans first ate fish 40,000 years agoJuly 7th, 2009 WASHINGTON - Freshwater fish remains a staple in many regions of the world, but it remains unclear when it became a year-round diet for early humans. A new study led by Erik Trinkaus, anthropology professor at Washington University, St.
Dominican police say 2 suspected drug dealers die of smoke after setting evidence on fireJune 17th, 2009 DomRep police: Smoke kills 2 who set cocaine afireSANTO DOMINGO, Dominican Republic — Dominican authorities say two suspected drug dealers have died of smoke inhalation after trying to burn cocaine before police could find it. The spokesman of the National Drug Control agency says that Mauricio Encarnacion Castillo and Ramon Antonio del Rosario set the evidence on fire after exchanging gunfire with police conducting a raid.
FDA tells parents to keep children on ADHD drugs, despite new evidence of sudden death risksJune 15th, 2009 FDA urges caution in weighing risks of ADHD drugsWASHINGTON — Federal health regulators are urging parents to keep their children on attention deficit drugs like Ritalin and Adderall, despite new evidence from a government-backed study that the stimulants can increase the risk of sudden death. Published Monday in the American Journal of Psychiatry, the study suggests a link between use of the stimulant drugs and sudden death in children and adolescents.
Merck's heart failure drug rolofylline misses main and backup goals in late-stage trialJune 5th, 2009 Merck's heart failure drug misses trial goalsWHITEHOUSE STATION, N.J. — Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo.
Power cuts cost India Inc over Rs.43,000 crore: StudyMay 27th, 2009 NEW DELHI - The global economic meltdown is not the only factor that is pulling down the revenues of Indian businesses. A study released here Wednesday said India Inc lost Rs.43,205 crore in 2008-09 due to power outages.
Stocks turn higher after sell-off; investors look for next catalyst for 2-month rallyMay 12th, 2009 Wall Street rises moderately after sell-offNEW YORK — Wall Street is rebounding moderately in early trading as investors look for the next catalyst to extend a two-month rally. With little economic data and few earnings reports due, investors likely will shift their attention to the government's report on retail sales later in the week, and retailers' first-quarter earnings figures.
Indian media, entertainment business valued at $11.68 bnFebruary 16th, 2009 MUMBAI - The Indian media and entertainment industry was a $11.68 billion (Rs.584 billion) business in 2008, growing at 15 percent annually since 2006, says the annual joint study of a leading chamber and a consultancy released here Tuesday. But the growth projection for the industry for 2009-13 has been lowered to 12.5 percent per annum from 18 percent for 2008-12, says the joint study by the Federation of Indian Chambers of Commerce and Industry (FICCI) and KPMG.